Search research articles
Contact Us
Filters
Showing results (641-650 of 678) with videos related to
Page
of 68
Sort By:
Nature Methods
|
July 17, 2019
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Gigi C G Choi, Peng Zhou, Chaya T L Yuen, et al.
Reproduction (Cambridge, England)
|
February 8, 2005
Cats cloned from fetal and adult somatic cells by nuclear transfer
X J Yin, H S Lee, Y H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2016
Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
Alan S L Wong, Gigi C G Choi, Cheryl H Cui, et al.
International Journal of Impotence Research
|
February 27, 2009
The relationship between body fat mass and erectile dysfunction in Korean men: Hallym Aging Study
Y-G Cho, H-J Song, S-K Lee, et al.
Transplantation Direct
|
November 13, 2024
A Multicenter Home-based Prehabilitation Intervention in Kidney Transplant Candidates
Elizabeth C Lorenz, Amanda R Bonikowske, Ashley C David-Van Meter, et al.
Neurogastroenterology and Motility
|
February 18, 2011
The role of small intestinal bacterial overgrowth in postgastrectomy patients
C N Paik, M-G Choi, C H Lim, et al.
Japanese Journal of Clinical Oncology
|
February 24, 2001
A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer
J Y Han, K W Kim, J A Kim, et al.
European Review for Medical and Pharmacological Sciences
|
September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cells
H S Chae, O H Kang, J H Keum, et al.
Clinical Immunology (Orlando, Fla.)
|
December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
J J Hofstra, I Kleine Budde, E van Twuyver, et al.
The Oncologist
|
December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Jin G Choi, Ryan D Nipp, Angela Tramontano, et al.
Page
of 68
Search research articles
Search
Showing results (641-650 of 678) with videos related to
Sort By:
Page
of 68
Nature Methods
|
July 17, 2019
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Gigi C G Choi, Peng Zhou, Chaya T L Yuen, et al.
Reproduction (Cambridge, England)
|
February 8, 2005
Cats cloned from fetal and adult somatic cells by nuclear transfer
X J Yin, H S Lee, Y H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2016
Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
Alan S L Wong, Gigi C G Choi, Cheryl H Cui, et al.
International Journal of Impotence Research
|
February 27, 2009
The relationship between body fat mass and erectile dysfunction in Korean men: Hallym Aging Study
Y-G Cho, H-J Song, S-K Lee, et al.
Transplantation Direct
|
November 13, 2024
A Multicenter Home-based Prehabilitation Intervention in Kidney Transplant Candidates
Elizabeth C Lorenz, Amanda R Bonikowske, Ashley C David-Van Meter, et al.
Neurogastroenterology and Motility
|
February 18, 2011
The role of small intestinal bacterial overgrowth in postgastrectomy patients
C N Paik, M-G Choi, C H Lim, et al.
Japanese Journal of Clinical Oncology
|
February 24, 2001
A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer
J Y Han, K W Kim, J A Kim, et al.
European Review for Medical and Pharmacological Sciences
|
September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cells
H S Chae, O H Kang, J H Keum, et al.
Clinical Immunology (Orlando, Fla.)
|
December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
J J Hofstra, I Kleine Budde, E van Twuyver, et al.
The Oncologist
|
December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Jin G Choi, Ryan D Nipp, Angela Tramontano, et al.
Page
of 68